rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2009-9-14
|
pubmed:abstractText |
Elevated plasma phospholipid transfer protein (PLTP) expression may increase atherosclerosis in mice by reducing plasma HDL and increasing hepatic VLDL secretion. Hepatic lipase (HL) is a lipolytic enzyme involved in several aspects of the same pathways of lipoprotein metabolism. We investigated whether the effects of elevated PLTP activity are compromised by HL deficiency.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-3002
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
1791
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1031-6
|
pubmed:meshHeading |
pubmed-meshheading:19524061-Animals,
pubmed-meshheading:19524061-Cholesterol, HDL,
pubmed-meshheading:19524061-Cholesterol, VLDL,
pubmed-meshheading:19524061-Lipase,
pubmed-meshheading:19524061-Lipoprotein Lipase,
pubmed-meshheading:19524061-Membrane Proteins,
pubmed-meshheading:19524061-Mice,
pubmed-meshheading:19524061-Mice, Transgenic,
pubmed-meshheading:19524061-Phospholipid Transfer Proteins
|
pubmed:year |
2009
|
pubmed:articleTitle |
Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.
|
pubmed:affiliation |
Department of Cell Biology and Genetics, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article
|